Indian Pharmacopoeia 2026 becomes first in world to establish exclusive standards for blood
The Indian Pharmacopoeia 2026 has achieved a historic milestone by becoming the first pharmacopoeia in the world to establish exclusive standards for blood. This landmark development sets a new benchmark for ensuring the quality, safety and efficacy of blood and blood products globally.
The pharmacopoeial monographs prescribe standards to ensure the identity, purity and strength of given drugs through botanical identification, various physico-chemical parameters and the like. For blood, these standards will cover a wide range of parameters including blood grouping, component separation, storage conditions and pathogen reduction.
According to the Indian Pharmacopoeia Commission, the new standards are based on extensive research and collaboration with experts from blood banks, hospitals and regulatory bodies. The move is expected to enhance patient safety and streamline blood transfusion practices across the country.
Details of the new standards
The exclusive standards for blood include monographs for whole blood, packed red cells, platelet concentrates, fresh frozen plasma and cryoprecipitate. Each monograph specifies requirements for collection, processing, storage and transport.
Key parameters include sterility tests, endotoxin limits, hemoglobin content, platelet count and coagulation factor assays. The standards also mandate screening for transfusion-transmissible infections such as HIV, hepatitis B and C, syphilis and malaria.
Impact on healthcare and regulatory framework
The introduction of these standards is expected to significantly improve the quality of blood products available in India. It will provide a uniform framework for blood banks and transfusion services to follow, reducing variability and enhancing safety.
Dr. V.G. Somani, Drug Controller General of India, stated: "This is a proud moment for India. The Indian Pharmacopoeia 2026 sets a global precedent by including comprehensive blood standards. It reflects our commitment to ensuring the highest quality of healthcare products for our citizens."
The Indian Pharmacopoeia Commission has also announced plans to update the standards regularly to keep pace with scientific advancements. Training programs for blood bank personnel are being organized to facilitate implementation.
